Vaccination against RSV

The Natural History of Respiratory Syncytial Virus in a Birth Cohort: The Influence of Age and Previous Infection on Reinfection and Disease

(2012) E. O. Ohuma et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Hospitalizations Associated With Influenza and Respiratory Syncytial Virus in the United States, 1993–2008

(2012) Hong Zhou et al.   CLINICAL INFECTIOUS DISEASES

Prevention of serious respiratory syncytial virus-related illness. I: Disease pathogenesis and early attempts at prevention

(2011) Jessie R. Groothuis et al.   ADVANCES IN THERAPY

Respiratory syncytial virus vaccine development

(2011) Julia L Hurwitz   Expert Review of Vaccines

Phase 1 Study of the Safety and Immunogenicity of a Live, Attenuated Respiratory Syncytial Virus and Parainfluenza Virus Type 3 Vaccine in Seronegative Children

(2011) David I. Bernstein et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Progress in understanding and controlling respiratory syncytial virus: Still crazy after all these years

(2011) Peter L. Collins et al.   VIRUS RESEARCH

Adverse events in pregnant women following administration of trivalent inactivated influenza vaccine and live attenuated influenza vaccine in the Vaccine Adverse Event Reporting System, 1990-2009

(2010) Pedro L. Moro et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Implementation of Cocooning against Pertussis in a High-Risk Population

(2010) C. M. Healy et al.   CLINICAL INFECTIOUS DISEASES

Cost-effectiveness analysis of various pertussis vaccination strategies primarily aimed at protecting infants in the Netherlands

(2010) Tjalke A. Westra et al.   CLINICAL THERAPEUTICS

Prospects for defined epitope vaccines for respiratory syncytial virus

(2010) Robert Anderson et al.   Future Microbiology

Serum Antibodies Critically Affect Virus-Specific CD4+/CD8+ T Cell Balance during Respiratory Syncytial Virus Infections

(2010) D. Kruijsen et al.   JOURNAL OF IMMUNOLOGY

A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats

(2010) Myra N Widjojoatmodjo et al.   Virology Journal

Seasonal Variation of Maternally Derived Respiratory Syncytial Virus Antibodies and Association with Infant Hospitalizations for Respiratory Syncytial Virus

(2009) Lone Graff Stensballe et al.   JOURNAL OF PEDIATRICS

The Burden of Respiratory Syncytial Virus Infection in Young Children

(2009) Caroline Breese Hall et al.   NEW ENGLAND JOURNAL OF MEDICINE

PHASE-I STUDY MEDI-534, OF A LIVE, ATTENUATED INTRANASAL VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS AND PARAINFLUENZA-3 VIRUS IN SEROPOSITIVE CHILDREN

(2009) Margarita Gomez et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

The Level and Duration of RSV-Specific Maternal IgG in Infants in Kilifi Kenya

(2009) Rachel Ochola et al.   PLoS One

A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults ≥65 years of age

(2009) Joanne M. Langley et al.   VACCINE

Young Infants Can Develop Protective Levels of Neutralizing Antibody after Infection with Respiratory Syncytial Virus

(2008) Joshua J. Shinoff et al.   JOURNAL OF INFECTIOUS DISEASES

Comparison of the Safety and Immunogenicity of 2 Respiratory Syncytial Virus (RSV) Vaccines— Nonadjuvanted Vaccine or Vaccine Adjuvanted with Alum—Given Concomitantly with Influenza Vaccine to High‐Risk Elderly Individuals

(2008) Ann R. Falsey et al.   JOURNAL OF INFECTIOUS DISEASES

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG

(2008) S. M. Bueno et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA